CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.
May 15th 2024
As a cancer survivor, I’m pleading for more research on cancer related fatigue.
FDA Approves Jadenu, a Simpler Formulation for Administering Deferasirox
March 31st 2015The Food and Drug Administration (FDA) has approved Jadenu (deferasirox) for the treatment of chronic iron overload, a condition that can affect patients with myelodysplastic syndromes (MDS), sickle cell disease and thalassemia.